Renerva, Inc.
Pittsburgh, PA
- UEI
- LJ97PLMMTGV1
- CAGE
- 7W0Q0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2403 Sidney St #280, Pittsburgh, PA 15203, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Renerva, Inc.
Renerva LLC is a for-profit biomedical company based in Pittsburgh, Pennsylvania, specializing in developing advanced peripheral nerve regeneration technologies. The company focuses on creating innovative medical solutions for nerve injury repair and regeneration, with a primary emphasis on developing tissue-based matrices and medical devices that address challenging neurological and neuromuscular conditions. Registered in the System for Award Management (SAM) since June 2017, Renerva operates as a corporate entity that manufactures specialized medical products targeting nerve injury treatment and functional recovery.
The company has been awarded multiple federal grants from the National Institute of Neurological Disorders and Stroke (NINDS) and the National Science Foundation (NSF), totaling approximately $2 million across four distinct project grants. These grants support the development of Peripheral Nerve Matrix (PNM) technologies, including a nerve capping device to prevent painful neuroma formation in peripheral nerve injuries and amputations, a tissue-based hydrogel for nerve gap injury repair, and research on direct muscle neurotization procedures. The grants span research areas such as improving functional outcomes for patients with peripheral nerve injuries, addressing nerve regeneration challenges, and developing innovative solutions for nerve repair. Renerva's technologies are derived from porcine nerve tissue and aim to provide advanced regenerative solutions for conditions involving nerve damage, with potential applications in treating motor and sensory impairments resulting from traumatic or surgical nerve injuries.
Quick answers
What is Renerva, Inc.'s UEI?
Renerva, Inc.'s Unique Entity ID (UEI) in SAM.gov is LJ97PLMMTGV1.
What is Renerva, Inc.'s CAGE code?
Renerva, Inc.'s CAGE code is 7W0Q0.
What is Renerva, Inc.'s primary NAICS code?
Renerva, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Renerva, Inc. located?
Renerva, Inc.'s physical address in SAM.gov is 2403 Sidney St #280, Pittsburgh, PA 15203, USA.
Is Renerva, Inc. registered in SAM.gov?
Yes. Renerva, Inc.'s SAM.gov registration is active through January 21, 2027.
What is Renerva, Inc.'s most recent federal award?
Renerva, Inc.'s most recent federal grant award is PNM-cap: a novel nerve cap to prevent painful neuroma formation in peripheral nerve injuries and amputations - 2.1M… (R43NS139719), from National Institute of Neurological Disorders and Stroke, on September 1, 2025.
On GovTribe
See Renerva, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors